Welcome to Pathology's Bi-Weekly Bulletin | Sept 20, 2024
|
Notification #2: Your Email will move to Microsoft Exchange Online on October 2nd!
As a follow-up to our previous communication here , we’d like to remind you that the M365 migration is scheduled for October 2nd at 2am PST. Please ensure you close your Outlook at the end of the workday on October 1st.
Please see the attached link with more instructions Exchange Online Migration.
After your email has been migrated to Microsoft Exchange Online, webmail will be available to you 24/7 at a new webmail link, outlook.office.com .
|
Big Congratulations to Genevieve MacMillan!
We are pleased to announce that Genevieve MacMillan, Director of Pathology & Laboratory Medicine, has been honored with the Dean’s Staff Award. This award recognizes her outstanding commitment to the Faculty of Medicine’s core values: respect, integrity, compassion, collaboration, and equity. Congratulations on this well-deserved recognition!
|
Staff Update
Sneha Dabgar, Executive Assistant in UBC Pathology and Laboratory Medicine, is leaving UBC for a position with Vancouver Acute within Vancouver Coastal Health Authority. Her last day with UBC Pathology and Laboratory Medicine is September 20th. We are in the process of hiring a replacement for Sneha and in the short term if you are needing the Vice Chair of Research’s signature on research documents or a meeting with the Department Head, please direct your queries to Genevieve at Genevieve.macmillan@ubc.ca.
|
Recently Published Work
We are pleased to highlight the recent scholarly contributions of our faculty members. Below are some of the latest refereed publications:
- 🔹 New paper from Dr. Stephen Yip:
"Splice of Life: How RNA is Rewriting the Meningioma Story" in Neuro-Oncology.
Read more.
- 🔹 Pathology members Fang Fang Li, David M. Goldfarb, Inna Sekirov, Natalie A. Prystajecky, Jocelyn A. Srigley, and Agatha N. Jassem have co-authored a new paper titled "Clinical Application of Phage Immunoprecipitation Sequencing to Diagnose Enterovirus D68 as the Underlying Etiology in a Case of Guillain-Barré Syndrome." The study focuses on diagnosing Enterovirus D68 as the cause of Guillain-Barré Syndrome using phage immunoprecipitation sequencing.
Read more.
- 🔹 Dr. Yen Chen Kevin Ko, Clinical Assistant Professor, and his team have published two papers in Modern Pathology that are gaining global attention for their work on the p53 classification system in oral dysplasia and oral squamous cell carcinoma (SCC).
p53-Abnormal Oral Epithelial Dysplasias Are Associated with High Risks of Progression and Local Recurrence - a Retrospective Study in a Longitudinal Cohort and Abnormal p53 Immunohistochemical Patterns Are Associated with Regional Lymph Node Metastasis in Oral Cavity Squamous Cell Carcinoma at Time of Surgery
Dr. Ko has been invited to present at several upcoming conferences, including MGH/BWH Grand Rounds on October 10, the American College of Oral and Maxillofacial Surgeons Annual Conference on October 26, the American Society of Dermatopathology on November 4, and Alberta Central Grand Rounds on November 14, 2024.
- 🔹
New Pre-Print Series: EQA Providers and Laboratory Quality. The CMP Lucy Perrone Lab is excited to announce that 4 out of 5 papers from their series on the role of EQA providers in ensuring laboratory quality are now live as pre-prints. This series involved over 100 experts from more than 20 EQA organizations and took two years to complete. Kudos to Anna and Veronica for their valuable contributions!
Behind the scenes of EQA - Part I- PREPRINT | Behind the scenes of EQA - Part II - PREPRINT.pdf | Behind the scenes of EQA - Part III - EQA samples- PREPRINT.pdf | Behind the scenes of EQA - Part IV- PREPRINT.pdf.
|
Virtual Info Sessions for 2025 CaRMS Applicants
We are hosting a series of virtual info sessions for 2025 CaRMS applicants in early October. Each session will feature program directors, associate directors, and lead residents from various residency programs, including Hematopathology, Medical Microbiology, Neuropathology, and Diagnostic and Molecular Pathology.
For more details and to register, visit the info sessions page.
|
"Decoding Cancer: How the Genomics Revolution Changed the Path for Cancer Management"
Genome BC proudly presents the Annual Don Rix Distinguished Keynote Address on November 18, 2024, featuring Dr. Sam Aparicio. Between 2006 and 2012, there were dramatic technological advances in the sequencing speed, cost and interpretation of human genomes. This year’s keynote address will explore how these advancements revolutionized our understanding of how cancers begin, evolve and develop drug resistance.
As a result, the development of cancer drugs has accelerated and we’ve created new ways to diagnose and manage cancers that were previously intractable. Dr. Aparicio will highlight British Columbia’s pivotal role in this scientific revolution and discuss ongoing challenges at the frontiers of cancer research.
This free event is open to everyone, and you can register here.
|
Pathology Picks:
Here are some additional reads you might be interested in:
- Last Chance to Join Our “Mediterranean Wellness Journey”! Don’t miss out on our Mediterranean Wellness Journey, starting on September 27th. Learn Mediterranean recipes, get practical tips on healthy eating, and join virtual and in-person sessions led by Michele Blanchet, RD. The program runs for four weeks and includes cooking demos, group discussions, and a final potluck. For more details and to register, click here. here.
- AI in Cancer Diagnosis: AI is revolutionizing cancer diagnosis with new methods. How will innovations like AIDA impact accuracy and adaptability? This technology promises significant improvements in the field of digital diagnostics. Learn more from UBC's Ali Bashashati and Maryam Asadi in their article in The Academic. Read the full article: here. You can explore the research here.
- Molecular Biology Workshop at UBC (Dec 9th to 13th, 2024) register . Please note: all revenue from this workshop goes towards their STEM outreach programming.
- Launch of 2024 Research Facility Support Grants The application deadline is November 1, 2024. The RFSG competition is open to faculty at the UBC Vancouver campus and affiliated hospital sites. Grants provide up to $50,000 for one year to enhance shared equipment capabilities or offer bridge funding for staff support in shared facilities.For more details, click here or contact Stacey Herzer if you have any questions at Stacey.herzer@ubc.ca.
- New Funding Opportunity - Societal Issues Competition Information about the opportunity, including a recording of the information session and the SOC4 guidelines, is available here: https://www.genomebc.ca/funding-opportunity/societal-issues-competition-intake-4. The due date for Statements of Interest (SOIs) is October 7, 2024
|
|
|
|
|
|
